Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report

Here, we present a case of relapsing–remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudi, Farhad, Emami, Sayed Ali, Masaeli, Farid, Rayatpisheh, Najmeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675105/
https://www.ncbi.nlm.nih.gov/pubmed/38028047
http://dx.doi.org/10.1002/ccr3.8143
_version_ 1785149782777397248
author Mahmoudi, Farhad
Emami, Sayed Ali
Masaeli, Farid
Rayatpisheh, Najmeh
author_facet Mahmoudi, Farhad
Emami, Sayed Ali
Masaeli, Farid
Rayatpisheh, Najmeh
author_sort Mahmoudi, Farhad
collection PubMed
description Here, we present a case of relapsing–remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care.
format Online
Article
Text
id pubmed-10675105
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106751052023-11-25 Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report Mahmoudi, Farhad Emami, Sayed Ali Masaeli, Farid Rayatpisheh, Najmeh Clin Case Rep Case Report Here, we present a case of relapsing–remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care. John Wiley and Sons Inc. 2023-11-25 /pmc/articles/PMC10675105/ /pubmed/38028047 http://dx.doi.org/10.1002/ccr3.8143 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Mahmoudi, Farhad
Emami, Sayed Ali
Masaeli, Farid
Rayatpisheh, Najmeh
Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
title Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
title_full Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
title_fullStr Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
title_full_unstemmed Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
title_short Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
title_sort alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675105/
https://www.ncbi.nlm.nih.gov/pubmed/38028047
http://dx.doi.org/10.1002/ccr3.8143
work_keys_str_mv AT mahmoudifarhad alemtuzumabinducedpetechiaeandepistaxisinapatientwithrelapsingremittingmultiplesclerosisacasereport
AT emamisayedali alemtuzumabinducedpetechiaeandepistaxisinapatientwithrelapsingremittingmultiplesclerosisacasereport
AT masaelifarid alemtuzumabinducedpetechiaeandepistaxisinapatientwithrelapsingremittingmultiplesclerosisacasereport
AT rayatpishehnajmeh alemtuzumabinducedpetechiaeandepistaxisinapatientwithrelapsingremittingmultiplesclerosisacasereport

Ejemplares similares